{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:17:51Z","timestamp":1793189871294,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Severe COVID-19 is characterized by immune-coagulation dysregulation, yet the contribution of related autoantibodies remains poorly understood. We investigated relationships between plasma autoantibody reactivities, whole-blood transcriptomics, plasma proteomics, and clinical laboratory parameters in a cohort of hospitalized COVID-19 patients. Transcriptomic analysis revealed that 42 curated coagulation and complement cascade genes were upregulated in severe cases compared to healthy controls, with 15 genes, including CR1L, ELANE, ITGA2B, ITGB3, VWF, TFPI, PROS1, MMRN1, and SELP (&gt;\u20091.2 log2 fold-change), also significantly different from mild cases. Autoantibody profiling against eight coagulation-related proteins (ADAMTS13, Factor V, Protein S, SERPINC1, Apo-H, PROC1, Prothrombin, and PF4) showed reactivities below positivity thresholds across all groups. Using an exploratory approach, in severe cases, subthreshold autoantibody candidates (FDR\u2009&lt;\u20090.25) showed negative correlation trends with select gene expressions and inflammatory markers (Factor V with IL-6 and CXCL10), suggesting potential disease-specific immunomodulatory associations. In contrast, while mild cases exhibited stronger gene-protein correlations, they showed limited associations with antigen reactivities or clinical laboratory parameters. Additionally, no correlations were observed between autoantibodies and platelet-counts or Fibrin-D-dimer levels. Age-associated increases in antigen reactivities were noted in severe disease, implying a role for immunosenescence. These findings support further investigation into the role of subthreshold autoantibody candidates in thromboinflammatory COVID-19 pathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-025-17054-6","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:28:55Z","timestamp":1756726135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune-coagulation dynamics in severe COVID-19 revealed by autoantibody profiling and multi-omics integration"],"prefix":"10.1038","volume":"15","author":[{"given":"Anoop T.","family":"Ambikan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Cederholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sefanit","family":"Rezene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Aranda-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hampus","family":"Nordqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Johan","family":"Treutiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo","family":"Lira-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Landegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"17054_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319\u2013329. https:\/\/doi.org\/10.1038\/s41577-021-00536-9 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"17054_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","volume":"17","author":"L Perico","year":"2021","unstructured":"Perico, L. et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol. 17, 46\u201364. https:\/\/doi.org\/10.1038\/s41581-020-00357-4 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"17054_CR3","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/s2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose, R. J. & Manuel, A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respiratory Med. 8, e46\u2013e47. https:\/\/doi.org\/10.1016\/s2213-2600(20)30216-2 (2020).","journal-title":"Lancet Respiratory Med."},{"key":"17054_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/CCM.0b013e3181c98d21","volume":"38","author":"M Levi","year":"2010","unstructured":"Levi, M. & van der Poll, T. Inflammation and coagulation. Crit. Care Med. 38, 26\u201334. https:\/\/doi.org\/10.1097\/CCM.0b013e3181c98d21 (2010).","journal-title":"Crit. Care Med."},{"key":"17054_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon, C. T. The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417\u2013430. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05753.x (2005).","journal-title":"Br. J. Haematol."},{"key":"17054_CR6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","volume":"26","author":"V Ramlall","year":"2020","unstructured":"Ramlall, V. et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat. Med. 26, 1609\u20131615. https:\/\/doi.org\/10.1038\/s41591-020-1021-2 (2020).","journal-title":"Nat. Med."},{"key":"17054_CR7","doi-asserted-by":"publisher","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Sci. (New York, N.Y.). 370, https:\/\/doi.org\/10.1126\/science.abd4585 (2020).","DOI":"10.1126\/science.abd4585"},{"key":"17054_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288. https:\/\/doi.org\/10.1038\/s41586-021-03631-y (2021).","journal-title":"Nature"},{"key":"17054_CR9","doi-asserted-by":"publisher","unstructured":"Zuo, Y. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 12, https:\/\/doi.org\/10.1126\/scitranslmed.abd3876 (2020).","DOI":"10.1126\/scitranslmed.abd3876"},{"key":"17054_CR10","doi-asserted-by":"publisher","first-page":"e1010118","DOI":"10.1371\/journal.ppat.1010118","volume":"17","author":"M Emmenegger","year":"2021","unstructured":"Emmenegger, M. et al. Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS Pathog. 17, e1010118. https:\/\/doi.org\/10.1371\/journal.ppat.1010118 (2021).","journal-title":"PLoS Pathog."},{"key":"17054_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng, X. L. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu. Rev. Med. 66, 211\u2013225. https:\/\/doi.org\/10.1146\/annurev-med-061813-013241 (2015).","journal-title":"Annu. Rev. Med."},{"key":"17054_CR12","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.1038\/s41598-023-37405-5","volume":"13","author":"AAN Doevelaar","year":"2023","unstructured":"Doevelaar, A. A. N. et al. Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019. Sci. Rep. 13, 10501. https:\/\/doi.org\/10.1038\/s41598-023-37405-5 (2023).","journal-title":"Sci. Rep."},{"key":"17054_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2588-y (2020).","journal-title":"Nature"},{"key":"17054_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076. https:\/\/doi.org\/10.1038\/s41591-020-0944-y (2020).","journal-title":"Nat. Med."},{"key":"17054_CR15","doi-asserted-by":"publisher","unstructured":"Ambikan, A. T. et al. Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity. Cell systems 13, 665\u2013681 e664,\u00a0https:\/\/doi.org\/10.1016\/j.cels.2022.06.006 (2022).","DOI":"10.1016\/j.cels.2022.06.006"},{"key":"17054_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"17054_CR17","doi-asserted-by":"publisher","DOI":"10.3791\/55768","author":"C Weidner","year":"2017","unstructured":"Weidner, C. et al. A protocol for using gene set enrichment analysis to identify the appropriate animal model for translational research. J. Visualized Experiments: JoVE. https:\/\/doi.org\/10.3791\/55768 (2017).","journal-title":"J. Visualized Experiments: JoVE"},{"key":"17054_CR18","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/bioinformatics\/btn120","volume":"24","author":"R Higdon","year":"2008","unstructured":"Higdon, R., van Belle, G. & Kolker, E. A note on the false discovery rate and inconsistent comparisons between experiments. Bioinf. (Oxford England). 24, 1225\u20131228. https:\/\/doi.org\/10.1093\/bioinformatics\/btn120 (2008).","journal-title":"Bioinf. (Oxford England)"},{"key":"17054_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41586-023-06717-x","volume":"623","author":"T Le Voyer","year":"2023","unstructured":"Le Voyer, T. et al. Autoantibodies against type I IFNs in humans with alternative NF-\u03baB pathway deficiency. Nature 623, 803\u2013813. https:\/\/doi.org\/10.1038\/s41586-023-06717-x (2023).","journal-title":"Nature"},{"key":"17054_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-020-00832-x","volume":"22","author":"E Brunetta","year":"2021","unstructured":"Brunetta, E. et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat. Immunol. 22, 19\u201324. https:\/\/doi.org\/10.1038\/s41590-020-00832-x (2021).","journal-title":"Nat. Immunol."},{"key":"17054_CR21","doi-asserted-by":"publisher","unstructured":"Napolitano, F. & Montuori, N. The N-formyl peptide receptors: much more than chemoattractant receptors. Relevance in health and disease. Front. Immunol. 16, https:\/\/doi.org\/10.3389\/fimmu.2025.1568629 (2025).","DOI":"10.3389\/fimmu.2025.1568629"},{"key":"17054_CR22","doi-asserted-by":"publisher","first-page":"100159","DOI":"10.1016\/j.mcpro.2021.100159","volume":"20","author":"S Krishnan","year":"2021","unstructured":"Krishnan, S. et al. Metabolic perturbation associated with COVID-19 disease severity and SARS-CoV-2 replication. Mol. Cell. Proteomics: MCP. 20, 100159. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100159 (2021).","journal-title":"Mol. Cell. Proteomics: MCP"},{"key":"17054_CR23","doi-asserted-by":"publisher","first-page":"668507","DOI":"10.3389\/fimmu.2021.668507","volume":"12","author":"F Coperchini","year":"2021","unstructured":"Coperchini, F., Chiovato, L. & Rotondi, M. Interleukin-6, CXCL10 and infiltrating macrophages in COVID-19-Related cytokine storm: not one for all but all for one! Front. Immunol. 12, 668507. https:\/\/doi.org\/10.3389\/fimmu.2021.668507 (2021).","journal-title":"Front. Immunol."},{"key":"17054_CR24","doi-asserted-by":"publisher","first-page":"145145","DOI":"10.1016\/j.gene.2020.145145","volume":"766","author":"M Sugiyama","year":"2021","unstructured":"Sugiyama, M. et al. Serum CCL17 level becomes a predictive marker to distinguish between mild\/moderate and severe\/critical disease in patients with COVID-19. Gene 766, 145145. https:\/\/doi.org\/10.1016\/j.gene.2020.145145 (2021).","journal-title":"Gene"},{"key":"17054_CR25","doi-asserted-by":"publisher","unstructured":"Guizani, I., Fourti, N., Zidi, W., Feki, M. & Allal-Elasmi, M. SARS-CoV-2 and pathological matrix remodeling mediators. Inflammation research: official journal of the European Histamine Research Society\u2026 [et al.] 70, 847\u2013858, https:\/\/doi.org\/10.1007\/s00011-021-01487-6 (2021).","DOI":"10.1007\/s00011-021-01487-6"},{"key":"17054_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2174\/156652409788167078","volume":"9","author":"N Cummins","year":"2009","unstructured":"Cummins, N. & Badley, A. The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr. Mol. Med. 9, 495\u2013505. https:\/\/doi.org\/10.2174\/156652409788167078 (2009).","journal-title":"Curr. Mol. Med."},{"key":"17054_CR27","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1096\/fj.14-257352","volume":"28","author":"D Haridas","year":"2014","unstructured":"Haridas, D. et al. MUC16: molecular analysis and its functional implications in benign and malignant conditions. FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology. 28, 4183\u20134199. https:\/\/doi.org\/10.1096\/fj.14-257352 (2014).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"},{"key":"17054_CR28","doi-asserted-by":"publisher","unstructured":"Smet, A. et al. A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity. JCI Insight. 6, https:\/\/doi.org\/10.1172\/jci.insight.151777 (2021).","DOI":"10.1172\/jci.insight.151777"},{"key":"17054_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s43587-021-00114-7","volume":"1","author":"JM Bartleson","year":"2021","unstructured":"Bartleson, J. M. et al. SARS-CoV-2, COVID-19 and the ageing immune system. Nat. Aging. 1, 769\u2013782. https:\/\/doi.org\/10.1038\/s43587-021-00114-7 (2021).","journal-title":"Nat. Aging"},{"key":"17054_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41514-023-00118-0","volume":"9","author":"DLM Fonseca","year":"2023","unstructured":"Fonseca, D. L. M. et al. Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting Cardiolipin and platelet glycoprotein with age: a systems biology approach. Npj Aging. 9, 21. https:\/\/doi.org\/10.1038\/s41514-023-00118-0 (2023).","journal-title":"Npj Aging"},{"key":"17054_CR31","doi-asserted-by":"publisher","first-page":"8941","DOI":"10.1038\/s41467-024-53356-5","volume":"15","author":"AF Jernbom","year":"2024","unstructured":"Jernbom, A. F. et al. Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19. Nat. Commun. 15, 8941. https:\/\/doi.org\/10.1038\/s41467-024-53356-5 (2024).","journal-title":"Nat. Commun."},{"key":"17054_CR32","doi-asserted-by":"publisher","first-page":"eadg7942","DOI":"10.1126\/science.adg7942","volume":"383","author":"C Cervia-Hasler","year":"2024","unstructured":"Cervia-Hasler, C. et al. Persistent complement dysregulation with signs of thromboinflammation in active long Covid. Sci. (New York N Y). 383, eadg7942. https:\/\/doi.org\/10.1126\/science.adg7942 (2024).","journal-title":"Sci. (New York N Y)"},{"key":"17054_CR33","doi-asserted-by":"publisher","first-page":"24512","DOI":"10.1038\/s41598-024-75514-x","volume":"14","author":"A Yalcinkaya","year":"2024","unstructured":"Yalcinkaya, A. et al. Autoantibodies to protein S May explain rare cases of coagulopathy following COVID-19 vaccination. Sci. Rep. 14, 24512. https:\/\/doi.org\/10.1038\/s41598-024-75514-x (2024).","journal-title":"Sci. Rep."},{"key":"17054_CR34","doi-asserted-by":"publisher","first-page":"W168","DOI":"10.1093\/nar\/gkad393","volume":"51","author":"JE Evangelista","year":"2023","unstructured":"Evangelista, J. E. et al. Enrichr-KG: bridging enrichment analysis across multiple libraries. Nucleic Acids Res. 51, W168\u2013W179. https:\/\/doi.org\/10.1093\/nar\/gkad393 (2023).","journal-title":"Nucleic Acids Res."},{"key":"17054_CR35","doi-asserted-by":"publisher","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology 15, 550,\u00a0https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"17054_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso, D., Ngai, J., Speed, T. P. & Dudoit, S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol. 32, 896\u2013902. https:\/\/doi.org\/10.1038\/nbt.2931 (2014).","journal-title":"Nat. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17054-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:28:56Z","timestamp":1756726136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17054-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17054"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17054-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Regional Ethics Committees of Stockholm (Dnr 2020\u2009\u2212\u200901865) and conducted in accordance with the Declaration of Helsinki.\u00a0Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}],"article-number":"32149"}}